Future research in ITP: an ICIS consensus

Zehnder, James L.; Semple, John W.; Imbach, Paul; Neufeld, Ellis J.; Buchanan, George R.; Cines, Douglas B.; ICIS Study Group on Future Research in ITP
July 2010
Annals of Hematology;Jul2010, Vol. 89, p19
Academic Journal
journal article
While much has been learned about the basic immunology and clinical characteristics of immune thrombocytopenia, many important questions remain with regard to pathogenesis, disease progression, identification of novel therapeutic targets and approaches, and clinical trials that rationalize and optimize use of existing therapies. The answers to these questions are likely to impact our understanding of the pathogenesis and therapeutic targets of autoimmune disease in general.


Related Articles

  • Evaluating bleeding severity in immune thrombocytopenia (ITP). Neunert, Cindy E. // Annals of Hematology;Jul2010, Vol. 89, p47 

    Despite immune thrombocytopenia (ITP) being one of the most common conditions encountered by the pediatric hematologist, relatively few prospective investigations of ITP exist, and treatment approaches remain highly variable. The ideal prospective clinical trial would use a reduction in severe...

  • PRIMARY PULMONARY TUBERCULOSIS IN A BOY WITH CHRONIC IMMUNE THROMBOCYTOPENIC PURPURA. ROŽMANIĆ, Vojko; LAH-TOMULIĆ, Kristina; AHEL, Vladimir; SMOKVINA, Miljenka; BANAC, Srđan; ČAČE, Neven // Pedijatrija Danas: Pediatrics Today;2010, Vol. 6 Issue 2, p207 

    No abstract available.

  • The role of Fcgamma receptors in murine autoimmune thrombocytopenia. Biburger, Markus; Aschermann, Susanne; Lux, Anja; Nimmerjahn, Falk // Annals of Hematology;Jul2010, Vol. 89, p25 

    Immune thrombocytopenia (ITP) can become a life-threatening condition that requires immediate medical attention. The loss in platelet numbers during ITP can be induced by a variety of triggers. Anti-platelet antibodies of several isotypes and subclasses are a major cause for ITP and are a...

  • Management of Immune Thrombocytopenic Purpura in Adults. Stasi, Roberto; Provan, Drew // Mayo Clinic Proceedings;Apr2004, Vol. 79 Issue 4, p504 

    Primary immune thrombocytopenic purpura (ITP), also referred to as idiopathic thrombocytopenic purpura, is an organ-specific autoimmune disorder in which antibodycoated or immune complex-coated platelets are destroyed prematurely by the reticuloendothelial system, resulting in peripheral blood...

  • Hidden maternal autoimmune thrombocytopenia complicated by fetal subdural hematoma-case report and review of the literature. Rios, Lívia; Araujo Júnior, Edward; Nardozza, Luciano; Haratz, Karina; Moron, Antonio; Martins, Marília // Child's Nervous System;Jul2012, Vol. 28 Issue 7, p1113 

    The article presents case study of having subdural hematoma related to fetal autoimmune thrombocytopenia. It has been informed that a 35-year-old primigravida was referred for routine scan at 34 gestational weeks (GW) and a full-term boy was delivered by cesarean section at 39 GW with a...

  • Successful treatment with intravenous immunoglobulin of severe thrombocytopenia complicated in primary Sjögren's syndrome. Choung, Bum-Su; Yoo, Wan-Hee // Rheumatology International;May2012, Vol. 32 Issue 5, p1353 

    Sjogren's syndrome (SS) is a systemic autoimmune disease characterized by xerophthalmia, xerostomia and extraglandular manifestations. Anemia, leukopenia, thrombocytopenia and lymphoproliferative disorders, including lymphoma are well-known extraglandular, hematological complications of SS. We...

  • The Ratio of Treg/Th17 Cells Correlates with the Disease Activity of Primary Immune Thrombocytopenia. Lili Ji; Yanxia Zhan; Fanli Hua; Feng Li; Shanhua Zou; Weiguang Wang; Dongli Song; Zhihui Min; Hao Chen; Yunfeng Cheng // PLoS ONE;Dec2012, Vol. 7 Issue 12, p1 

    Background: Primary immune thrombocytopenia (ITP) is an autoimmune heterogeneous disorder that is characterized by decreased platelet count. Regulatory T (Treg) cells and T helper type 17 (Th17) cells are two subtypes of CD4+ T helper (Th) cells. They play opposite roles in immune tolerance and...

  • Experiences with recombinant FVIIa in the emergency treatment of patients with autoimmune thrombocytopenia: a review of the literature. Salama, A.; Rieke, M.; Kiesewetter, H.; Depka, M.; von Depka, M // Annals of Hematology;Jan2009, Vol. 88 Issue 1, p11 

    Patients with severe and refractory autoimmune thrombocytopenia (ITP) have significant morbidity and mortality rates. Currently, high-dose methylprednisolone and/or high-dose IVIgG are recommended for the emergency treatment of such patients with uncontrolled bleeding. However, some patients do...

  • Consensus Paper-ICIS Expert Meeting Basel 2009 treatment milestones in immune thrombocytopenia. Tamary, Hannah; Roganovic, Jelena; Chitlur, Meera; Nugent, Diane; Nugent, Diane J // Annals of Hematology;Jul2010, Vol. 89, p5 

    The rarity of severe complications of this disease in children makes randomized clinical trials in immune thrombocytopenia (ITP) unfeasible. Therefore, the current management recommendations for ITP are largely dependent on clinical expertise and observations. As part of its discussions during...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics